Central Tuberculosis Division, Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India, New Delhi, India.
PLoS One. 2010 Jan 25;5(1):e8873. doi: 10.1371/journal.pone.0008873.
Under India's Revised National Tuberculosis Control Programme (RNTCP), >15% of previously-treated patients in the reported 2006 patient cohort defaulted from anti-tuberculosis treatment.
To assess the timing, characteristics, and risk factors for default amongst re-treatment TB patients.
For this case-control study, in 90 randomly-selected programme units treatment records were abstracted from all 2006 defaulters from the RNTCP re-treatment regimen (cases), with one consecutively-selected non-defaulter per case. Patients who interrupted anti-tuberculosis treatment for >2 months were classified as defaulters.
1,141 defaulters and 1,189 non-defaulters were included. The median duration of treatment prior to default was 81 days (25%-75% interquartile range 44-117 days) and documented retrieval efforts after treatment interruption were inadequate. Defaulters were more likely to have been male (adjusted odds ratio [aOR] 1.4, 95% confidence interval [CI] 1.2-1.7), have previously defaulted anti-tuberculosis treatment (aOR 1.3 95%CI 1.1-1.6], have previous treatment from non-RNTCP providers (AOR 1.3, 95%CI 1.0-1.6], or have public health facility-based treatment observation (aOR 1.3, 95%CI 1.1-1.6).
Amongst the large number of re-treatment patients in India, default occurs early and often. Improved pre-treatment counseling and community-based treatment provision may reduce default rates. Efforts to retrieve treatment interrupters prior to default require strengthening.
根据印度修订后的国家结核病控制规划(RNTCP),在报告的 2006 年患者队列中,超过 15%的既往治疗患者从抗结核治疗中退出。
评估再治疗结核病患者中退出治疗的时间、特征和危险因素。
在这项病例对照研究中,从 RNTCP 再治疗方案中随机选择了 90 个方案单位的治疗记录,从每个病例中选择了一个连续选择的非退出者,对所有 2006 年的退出者(病例)进行了分析。将中断抗结核治疗超过 2 个月的患者分类为退出者。
共纳入了 1141 名退出者和 1189 名非退出者。在退出前,治疗的中位数持续时间为 81 天(25%-75%四分位间距为 44-117 天),且中断治疗后的检索工作不充分。退出者更有可能为男性(调整后的优势比[aOR]1.4,95%置信区间[CI]1.2-1.7),以前曾因结核病治疗而退出(aOR 1.3,95%CI 1.1-1.6),以前曾接受非 RNTCP 提供者的治疗(AOR 1.3,95%CI 1.0-1.6),或接受基于公共卫生机构的治疗观察(aOR 1.3,95%CI 1.1-1.6)。
在印度大量的再治疗患者中,退出治疗的情况发生得早且经常。改进治疗前咨询和基于社区的治疗提供可能会降低退出率。需要加强在退出前检索中断治疗者的努力。